In this case, heterogeneous NAFLD presentations were induced with different diet-induced NAFLD rodent models, and a pretreatment biopsy was used to identify NAFLD rodents with high IGFBP-1 expression. This evidence concerns the gene IGFBP1 and metabolic dysfunction-associated steatotic liver disease.